unreported-man LDLo 1912 ug/kg "Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970.
intraperitoneal-mouse LD50 220 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 192, Pg. 88, 1971.
intravenous-mouse LD50 61900 ug/kg Drugs in Japan Vol. 6, Pg. APP-16, 1982.
oral-mouse LD50 119 mg/kg Drugs in Japan Vol. 6, Pg. APP-16, 1982.
intravenous-rabbit LDLo 120 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1386, 1935.
intraperitoneal-rat LD50 166 mg/kg Drugs in Japan Vol. 6, Pg. APP-16, 1982.
intravenous-rat LD50 88500 ug/kg Drugs in Japan Vol. 6, Pg. APP-16, 1982.
oral-rat LD50 402 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 1204, 1981.
|
subcutaneous-human LDLo 143 ug/kg BEHAVIORAL: COMA
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION Confinia Neurologica. Vol. 10, Pg. 8, 1949.
subcutaneous-mouse LD50 90900 ug/kg Drugs in Japan Vol. 6, Pg. APP-16, 1982.
subcutaneous-rat LD50 366 mg/kg Drugs in Japan Vol. 6, Pg. APP-16, 1982.
|